Braskem (BAK) Cash & Equivalents (2009 - 2025)

Braskem's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $1.9 billion for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 24.47% year-over-year to $1.9 billion; the TTM figure through Dec 2025 stood at $1.9 billion (down 24.47% YoY), while the FY2025 annual figure was $1.9 billion, down 24.47% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $1.9 billion, up from $1.9 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $2.9 billion in Q4 2023, with the low at $1.6 billion in Q4 2021.
• The 5-year median for Cash & Equivalents is $2.3 billion (2021), against an average of $2.3 billion.
• The sharpest annual moves came in 2021 and 2022: Cash & Equivalents tumbled 39.39% in 2021, then jumped 52.26% in 2022.
• Braskem's Cash & Equivalents stood at $1.6 billion in 2021, then surged by 52.26% to $2.4 billion in 2022, then gained by 20.94% to $2.9 billion in 2023, then fell by 10.02% to $2.6 billion in 2024, then retreated by 24.47% to $1.9 billion in 2025.
• Business Quant data shows BAK's Cash & Equivalents at $1.9 billion in Q4 2025, $1.9 billion in Q1 2025, and $2.6 billion in Q4 2024.